News

News and Press Releases
Research | Infection Prevention and Control International Study Reports COVID-19 Outcomes in People With Cystic Fibrosis

Collaborative effort identifies 40 cases of COVID-19 across eight countries; outcomes for this high-risk population were reported in the Journal of Cystic Fibrosis

| 4 min read
Research | About the CF Foundation | Clinical Trials | Our Research Approach CF Foundation Announces up to $5M Award to Support First-Ever Controlled Clinical Study of Phage Therapy in Cystic Fibrosis

Study reaffirms the Foundation's commitment to advance solutions to the growing challenge of antibiotic resistance and evaluate the use of phage to treat infections for people with CF

| 4 min read
About the CF Foundation | Our Research Approach | Research Cystic Fibrosis Foundation Launches $500 Million Path to a Cure

Nonprofit issues challenge to accelerate treatments for every person with CF

| 5 min read
Research | CFTR Modulators | Drug Pipeline Cystic Fibrosis Foundation statement on FDA approval of TRIKAFTA, the first triple combination therapy for the most common CF mutation

This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.  

| 3 min read
Research Cystic Fibrosis Foundation Commits $100 Million to Infection Research

Funding will support improved detection, diagnosis, prevention, and treatment of infections related to cystic fibrosis.

| 4 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Research Cystic Fibrosis Foundation Therapeutics Announces $14 Million Research Expansion with Genzyme

Program Aimed at Advancing Search for Therapies Targeting Most Common Mutation of CF

| 3 min read
About the CF Foundation | Public Policy | Research NIH Director Francis Collins and CF Foundation to Brief U.S. Senate on Advancing Disease Research

Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies

| 3 min read